196 related articles for article (PubMed ID: 37449370)
1. Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy.
Mirmovich Morvay O; Ramon M; Khamaysi Z; Avitan-Hersh E
Acta Derm Venereol; 2023 Jul; 103():adv6557. PubMed ID: 37449370
[TBL] [Abstract][Full Text] [Related]
2. Mycosis fungoides in pediatric population: comprehensive review on epidemiology, clinical presentation, and management.
Kothari R; Szepietowski JC; Bagot M; Sandhu S; Patil A; Grabbe S; Goldust M
Int J Dermatol; 2022 Dec; 61(12):1458-1466. PubMed ID: 35193164
[TBL] [Abstract][Full Text] [Related]
3. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
6. Phototherapy as a treatment of early-stage mycosis fungoides and predictive factors for disease recurrence: A 17-year retrospective study.
Rattanakaemakorn P; Ploydaeng M; Udompanich S; Thadanipon K; Rutnin S; Rajatanavin N
Indian J Dermatol Venereol Leprol; 2021; 87(5):645-650. PubMed ID: 33871205
[TBL] [Abstract][Full Text] [Related]
7. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature.
Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M
J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898
[TBL] [Abstract][Full Text] [Related]
8. The different faces of mycosis fungoides: results of a single-center study.
Sidiropoulou P; Nikolaou V; Marinos L; Voudouri D; Komini E; Economidi A; Rigopoulos D; Stratigos A
Int J Dermatol; 2020 Mar; 59(3):314-320. PubMed ID: 31782525
[TBL] [Abstract][Full Text] [Related]
9. Childhood mycosis fungoides: experience of 28 patients and response to phototherapy.
Laws PM; Shear NH; Pope E
Pediatr Dermatol; 2014; 31(4):459-64. PubMed ID: 24916067
[TBL] [Abstract][Full Text] [Related]
10. Phototherapy for mycosis fungoides.
Dogra S; Mahajan R
Indian J Dermatol Venereol Leprol; 2015; 81(2):124-35. PubMed ID: 25751327
[TBL] [Abstract][Full Text] [Related]
11. Folliculotropic mycosis fungoides: Clinical characteristics, treatments, and long-term outcomes of 53 patients in a tertiary hospital.
Kalay Yildizhan I; Sanli H; Akay BN; Uzundere C; Okcu Heper A
Dermatol Ther; 2020 Jul; 33(4):e13585. PubMed ID: 32410323
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
Amitay-Laish I; Prag-Naveh H; Dalal A; Pavlovsky L; Feinmesser M; Hodak E
Acta Derm Venereol; 2018 Nov; 98(10):951-955. PubMed ID: 30085321
[TBL] [Abstract][Full Text] [Related]
13. Perplexing Rash: Challenges to Diagnosis and Management of Mycosis Fungoides.
Aun JA; Patel HS; Patel KK; Cashman J; Bailey E
J Am Osteopath Assoc; 2018 Jul; 118(7):472-478. PubMed ID: 29946665
[TBL] [Abstract][Full Text] [Related]
14. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
15. [Epitheliotropic lymphomas: better identification for improved treatment].
Bagot M
Bull Acad Natl Med; 2010 Oct; 194(7):1365-72. PubMed ID: 22043631
[TBL] [Abstract][Full Text] [Related]
16. Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil.
Deonizio JM; Ascef RD; Sanches JA
Int J Dermatol; 2016 May; 55(5):e256-61. PubMed ID: 26711732
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology and prognostic factors of 114 patients with mycosis fungoides in a Moroccan cohort: a 29-year review.
Titou H; Bouhamidi A
Clin Exp Med; 2023 Nov; 23(7):3751-3758. PubMed ID: 37029872
[TBL] [Abstract][Full Text] [Related]
18. Mycosis fungoides in pediatric patients: Clinical features, diagnostic challenges, and advances in therapeutic management.
Wu JH; Cohen BA; Sweren RJ
Pediatr Dermatol; 2020 Jan; 37(1):18-28. PubMed ID: 31630432
[TBL] [Abstract][Full Text] [Related]
19. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract][Full Text] [Related]
20. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
